IL6 and COVID-19: Severe patients with COVID-19 more frequently had increased inflammatory monocytes and neutrophils and a sharp decrease in lymphocytes (Giamarellos-Bourboulis et al., 2020), with higher levels of IL-1β, IL-6, and TNF-α (Chen G. et al., 2020), leading to systemic organ failure and tissue damage.